3D Systems Acquires Volumetric Biotechnologies
3D Systems acquired Volumetric Biotechnologies in the fall of 2021, and it became the foundation for the world-class bioprinting facility being established in Houston, Texas. From this facility, 3D Systems is accelerating the development of vascularized human tissues and bioprinted constructs, and creating clear technological leadership in the rapidly emerging bioprinting field.
We are pleased to offer a number of materials from the Volumetric team as part of the 3D Systems portfolio.
Learn more about our bioprinting materials available for purchase.
Lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) Photoinitiator (Sterile-Filtered Aqueous Solution)
3400 Da Poly(ethylene glycol) diacrylate (PEGDA) powder
6000 Da Poly(ethylene glycol) diacrylate (PEGDA) powder
Sterile-filtered aqueous solution